<div id="readability-page-1"><p>Norden Group LLC decreased its position in shares of  Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 76.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor  owned 1,315 shares of the medical research company's stock after selling 4,226 shares during the period. Norden Group LLC's holdings in Thermo Fisher Scientific were worth $638,000 at the end of the most recent quarter.</p><ul><li>Sector Rotation: 2 Smart Money Moves for 2026</li></ul><p>Other hedge funds also recently modified their holdings of the company. Heathbridge Capital Management Ltd. acquired a new position in  Thermo Fisher Scientific during the third quarter worth about $230,000.  Triangle Securities Wealth Management boosted its position in shares of  Thermo Fisher Scientific by 5.2% during the 3rd quarter. Triangle Securities Wealth Management now owns 2,805 shares of the medical research company's stock valued at $1,360,000 after purchasing an additional 139 shares in the last quarter.  Founders Financial Securities LLC raised its holdings in shares of  Thermo Fisher Scientific by 11.1% in the 3rd quarter. Founders Financial Securities LLC now owns 2,367 shares of the medical research company's stock worth $1,148,000 after purchasing an additional 237 shares in the last quarter.  Cape ANN Savings Bank acquired a new stake in  Thermo Fisher Scientific during the third quarter valued at approximately $210,000.  Finally, Value Partners Investments Inc. grew its position in  Thermo Fisher Scientific by 1.6% in the third quarter. Value Partners Investments Inc. now owns 10,440 shares of the medical research company's stock worth $5,061,000 after buying an additional 160 shares during the last quarter. 89.23% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Analysts Set New Price Targets</h2><p>Several equities research analysts have recently weighed in on the company. Citigroup raised Thermo Fisher Scientific from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and raised their price objective for the stock from $580.00 to $660.00 in a research note on Thursday, December 11th. KeyCorp raised Thermo Fisher Scientific from a &#34;sector weight&#34; rating to an &#34;overweight&#34; rating and set a $750.00 price target on the stock in a research note on Sunday, December 7th. Hsbc Global Res upgraded Thermo Fisher Scientific from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Monday, December 1st. UBS Group raised their target price on shares of Thermo Fisher Scientific from $500.00 to $590.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, October 23rd. Finally, TD Cowen boosted their price target on shares of Thermo Fisher Scientific from $612.00 to $654.00 and gave the company a &#34;buy&#34; rating in a report on Thursday, October 23rd. One analyst  has rated the stock with a Strong Buy rating, twenty have given a Buy rating and three have assigned  a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $616.60.</p><ul><li>Institutions Love These 3 Companies, Should You As Well?</li></ul><p><b>Check Out Our Latest Report on Thermo Fisher Scientific</b></p><h2>Insider Transactions at Thermo Fisher Scientific</h2><p>In related news, VP Lisa P. Britt sold 10,225 shares of the business's stock in a transaction that occurred on Friday, November 7th. The stock was sold at an average price of $571.62, for a total value of $5,844,814.50. Following the completion of the sale, the vice president owned 14,145 shares of the company's stock, valued at approximately $8,085,564.90. The trade was a 41.96% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael D. Shafer sold 10,725 shares of the firm's stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $600.00, for a total transaction of $6,435,000.00. Following the transaction, the executive vice president directly owned 18,731 shares in the company, valued at approximately $11,238,600. The trade was a 36.41% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 149,271 shares of company stock valued at $86,507,282. Corporate insiders own  0.33% of the company's stock. </p><h2>Thermo Fisher Scientific Trading Up 0.3%</h2><ul><li>These 3 Stocks Are Using Buybacks to Signal Market Confidence</li></ul><p>NYSE:TMO opened at $580.65 on Friday. The stock has a market cap of $218.16 billion, a PE ratio of 33.54, a price-to-earnings-growth ratio of 4.11 and a beta of 0.90. Thermo Fisher Scientific Inc. has a fifty-two week low of $385.46 and a fifty-two week high of $610.97. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.50 and a quick ratio of 1.11. The stock's 50-day moving average is $573.94 and its two-hundred day moving average is $502.88. </p><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its quarterly earnings results on Wednesday, October 22nd. The medical research company reported $5.79 EPS for the quarter, topping the consensus estimate of $5.50 by $0.29. The business had revenue of $11.12 billion during the quarter, compared to analysts' expectations of $10.90 billion. Thermo Fisher Scientific had a net margin of 15.02% and a return on equity of 16.97%. The firm's quarterly revenue was up 4.9% compared to the same quarter last year. During the same period last year, the company posted $5.28 earnings per share. Thermo Fisher Scientific has set its FY 2025 guidance at 22.600-22.860 EPS.  As a group, equities research analysts forecast that  Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current fiscal year. </p><h2>Thermo Fisher Scientific Dividend Announcement</h2><p>The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Monday, December 15th will be issued a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, December 15th. Thermo Fisher Scientific's dividend payout ratio (DPR) is currently 9.94%. </p><p>Thermo Fisher Scientific announced that its board has initiated a stock repurchase plan on Thursday, November 6th that allows the company to repurchase $5.00 billion in    shares. This repurchase authorization allows the medical research company to reacquire up to 2.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company's management believes its shares are undervalued. </p><h2>Thermo Fisher Scientific Profile</h2> (Free Report)<p>Thermo Fisher Scientific <span>NYSE: TMO<span></span></span> is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.  </p><p>Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.</p><h2>Read More</h2><ul><li>Five stocks we like better than Thermo Fisher Scientific</li><li>Do not delete, read immediately</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li><li>Can Any Expenses Be Deducted From Capital Gains Tax?</li><li>Do you know what Amazon is planning for January 1?</li><li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li></ul><p><strong>Want to see what other hedge funds are holding TMO?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Norden Group LLC reduced its stake in Thermo Fisher Scientific by 76.3% in Q3, owning 1,315 shares worth $638,000. Other hedge funds adjusted their holdings, with analysts raising price targets and ratings. Insider transactions included significant stock sales by VP Lisa P. Britt and EVP Michael D. Shafer. The stock opened at $580.65, with a market cap of $218.16 billion.</p>

Thermo Fisher Scientific Inc. $TMO Stake Lessened by Norden Group LLC